铁烯和有机甲酸甲衍生物的合成和生物特性
Karolina Rózga1, Andrzej Błauż2, Daniel Moscoh Ayine-Tora3,4
1Department of Organic Chemistry, Faculty of Chemistry, University of Lodz, 12 Tamka, 91-403 Łódź, Poland.
ACS omega
|August 12, 2024
概括
修改后的甲托雷克萨特衍生物,包括含铁的化合物,在克服癌细胞多药性耐药性 (MDR) 方面表现有前途. 这些新型化合物有效地阻碍了癌细胞的增殖,即使在耐药的细胞系中也是如此.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 癌症生物学 癌症生物学
背景情况:
- 甲托雷克萨特 (MTX) 是一种重要的化疗剂,但其有效性通常受到多药耐药性 (MDR) 的限制.
- 开发新的MTX衍生品对于克服抗药性机制和改善治疗结果至关重要.
研究的目的:
- 合成和评估具有修改侧链的新型甲状腺衍生物.
- 研究这些衍生物在克服癌细胞中抗药性方面的潜力.
主要方法:
- 合成两系列MTX衍生物:铁-MTX和氨基酸替代的MTX.
- 生物评估包括二叶酸减少酶 (DHFR) 抑制试验.
- 对各种小鼠和人类细胞系进行细胞增殖测定,包括对MTX耐药的对应物.
- 分子建模和与Abcc1.1等MDR蛋白的相互作用研究.
主要成果:
- 铁基MTX衍生物显示中度的DHFR抑制,但有效地抑制了敏感和耐药细胞系的增殖,克服了MDR.
- 这些铁衍生物与MDR蛋白Abcc1.1直接相互作用.
- 氨基酸结合物显示出不同的DHFR抑制和对细胞活性的影响,γ-氨基黄油酸和氨酸衍生物表现出不同的活性.
结论:
- 修改甲托雷克萨特侧链是一种可行的策略,以克服依赖流量的MTX电阻.
- 铁装饰的MTX衍生物代表了对抗MDR癌症的一类有前途的化合物.
- 准像Abcc1这样的MDR蛋白可能是这些新型MTX类似物的一个关键机制.
相关概念视频
Phase II Reactions: Methylation Reactions
170
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
170
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Drug Metabolism: Phase II Reactions
3.7K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.7K
Stereoisomerism
11.8K
Isomerism in Complexes
Isomers are different chemical species that have the same chemical formula.
Transition metal complexes often exist as geometric isomers, in which the same atoms are connected through the same types of bonds but with differences in their orientation in space. Coordination complexes with two different ligands in the cis and trans positions from a ligand of interest form isomers. For example, the octahedral [Co(NH3)4Cl2]+ ion has two isomers (Figure 1) In the cis...
Isomers are different chemical species that have the same chemical formula.
Transition metal complexes often exist as geometric isomers, in which the same atoms are connected through the same types of bonds but with differences in their orientation in space. Coordination complexes with two different ligands in the cis and trans positions from a ligand of interest form isomers. For example, the octahedral [Co(NH3)4Cl2]+ ion has two isomers (Figure 1) In the cis...
11.8K


